510(k) device
LINQ II Insertable Cardiac Monitor (ICM) (LNQ22)
Medtronic, Inc. · Recorder, Event, Implantable Cardiac, (With Arrhythmia Detection) (MXD, Class II) · First FDA decision Jul 3, 2020, newest Aug 28, 2026Atrial fibrillation
Last checked: Nov 21, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
9
510(k) pathway
Device trials
0
Naming "LINQ II Insertable"
MAUDE reports
10,496
Brand "LINQ II Insertable", since 2015
PubMed studies
0
Mentioning "LINQ II Insertable"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing LINQ II Insertable Cardiac Monitor (ICM) (LNQ22)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 9 decisions filed under this name.
K262735 · Decided Aug 28, 2026 · 28 days after receipt
Device type: Recorder, Event, Implantable Cardiac, (With Arrhythmia Detection) (MXD) · Cardiology
5 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "LINQ II Insertable", any status and sponsor, newest update first.
No registered device study names "LINQ II Insertable".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "LINQ II Insertable", and for the whole product code for context.
This brand
10,496 reports: 10,059 malfunction, 435 injury, 2 death
Whole product code MXD
13,376 reports: 11,084 malfunction, 2,288 injury, 3 death
Newest reports for this brand
- LINQ II¿ Insertable Cardiac MonitorMalfunction
Medtronic Singapore Operations
3008973940-2026-08060 · Received Oct 30, 2026 · Event dated Oct 20, 2026
Device type: Recorder, Event, Implantable Cardiac, (With Arrhythmia Detection) (MXD)
Device problem as coded: Reset Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- ICM LNQ22 LINQ II, Model LNQ22; Insertable Cardiac MonitorOpen, Classified
Z-0421-2024 · Started Nov 3, 2023 · Posted by FDA Dec 1, 2023
Reason given: It may create the potential for amplified noise and/or overall signal reduction of the ICM, which may interfere with intended recordings of heart rhythms. This noise pattern is different from occasional noise due to device position/migration, patient activity, or external electromagnetic interference.
Cause as FDA categorized it: Process change control · Device type: Recorder, Event, Implantable Cardiac, (With Arrhythmia Detection) (MXD)
Published research
The most relevant PubMed records for "LINQ II Insertable"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code MXD.
- Reveal LINQ Insertable Cardiac MonitorMedtronic, Inc. · 510(k) 2023
- Reveal LINQMedtronic, Inc. · 510(k) 2017
- BioMonitor 2-AF, BioMonitor 2-S, FIT - Fast Insert Tool 1 + 2, SetBiotronik, Inc. · 510(k) 2017
- Biomonitor IV (471155)Biotronik, Inc. · 510(k) 2026
- LUX-Dx Insertable Cardiac MonitorBoston Scientific Corporation · 510(k) 2021
- Biomonitor III, Biomonitor IIImBiotronik, Inc. · 510(k) 2020
- BioMonitorBiotronik, Inc. · 510(k) 2015
- Assert-IQ (DM5100)Abbott Medical · 510(k) 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.